Industry / Puerto Rico
GSK Makes Second Settlement Over Puerto Rican Plant
June 2011 | Industry Trend AnalysisBMI Core View: Ensuring quality manufacturing standards is one of the fundamental responsibilities of pharmaceutical companies. Although costs will rise, we believe it necessary for firms, agencies and payers to work collectively and increase dialogue to ensure compliance to Good Manufacturing Practice (GMP) within the increasingly globalised pharmaceutical market. There needs to be a cohesive top-down and bottom-up approach to guarantee public safety and trust in the
To read the full article, please choose one of the following options:
Subcribers please log in




